BiocardiaInc Interest Expense vs Net Interest Income Analysis
BCDA Stock | USD 0.38 0.01 2.56% |
BiocardiaInc financial indicator trend analysis is way more than just evaluating BiocardiaInc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BiocardiaInc is a good investment. Please check the relationship between BiocardiaInc Interest Expense and its Net Interest Income accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BiocardiaInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade BiocardiaInc Stock refer to our How to Trade BiocardiaInc Stock guide.
Interest Expense vs Net Interest Income
Interest Expense vs Net Interest Income Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BiocardiaInc Interest Expense account and Net Interest Income. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between BiocardiaInc's Interest Expense and Net Interest Income is -0.25. Overlapping area represents the amount of variation of Interest Expense that can explain the historical movement of Net Interest Income in the same time period over historical financial statements of BiocardiaInc, assuming nothing else is changed. The correlation between historical values of BiocardiaInc's Interest Expense and Net Interest Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Interest Expense of BiocardiaInc are associated (or correlated) with its Net Interest Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Interest Income has no effect on the direction of Interest Expense i.e., BiocardiaInc's Interest Expense and Net Interest Income go up and down completely randomly.
Correlation Coefficient | -0.25 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Interest Expense
The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.Net Interest Income
The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.Most indicators from BiocardiaInc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BiocardiaInc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BiocardiaInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade BiocardiaInc Stock refer to our How to Trade BiocardiaInc Stock guide.At present, BiocardiaInc's Issuance Of Capital Stock is projected to increase significantly based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 12.57, whereas Selling General Administrative is forecasted to decline to about 3.3 M.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 9K | 6K | 6.9K | 6.6K | Depreciation And Amortization | 67K | 82K | 411K | 242.0K |
BiocardiaInc fundamental ratios Correlations
Click cells to compare fundamentals
BiocardiaInc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
BiocardiaInc fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 7.7M | 23.4M | 15.7M | 9.8M | 3.0M | 2.8M | |
Other Current Liab | 1.8M | 1.5M | 1.4M | 1.6M | 1.8M | 1.9M | |
Total Current Liabilities | 4.0M | 4.2M | 3.7M | 3.6M | 3.6M | 3.8M | |
Total Stockholder Equity | 2.4M | 19.2M | 10.4M | 4.9M | (1.6M) | (1.5M) | |
Property Plant And Equipment Net | 1.2M | 712K | 2.1M | 1.9M | 1.4M | 744.1K | |
Net Debt | (4.4M) | (20.8M) | (11.0M) | (5.7M) | 212K | 222.6K | |
Retained Earnings | (101.1M) | (116.1M) | (128.7M) | (140.6M) | (152.2M) | (144.6M) | |
Accounts Payable | 914K | 746K | 507K | 683K | 890K | 934.5K | |
Cash | 5.6M | 21.4M | 12.9M | 7.4M | 1.1M | 1.0M | |
Non Current Assets Total | 1.3M | 766K | 2.2M | 1.9M | 1.5M | 1.6M | |
Cash And Short Term Investments | 5.6M | 21.4M | 12.9M | 7.4M | 1.1M | 1.0M | |
Net Receivables | 274K | 147K | 850K | 201K | 63K | 59.9K | |
Common Stock Total Equity | 38K | 43K | 7K | 16K | 18.4K | 17.5K | |
Common Stock Shares Outstanding | 5.6M | 10.1M | 16.9M | 17.7M | 21.2M | 22.2M | |
Liabilities And Stockholders Equity | 7.7M | 23.4M | 15.7M | 9.8M | 3.0M | 2.8M | |
Non Current Liabilities Total | 1.3M | 2.7M | 1.6M | 1.3M | 982.0K | 630.9K | |
Other Current Assets | 642K | 1.3M | 462K | 501K | 295K | 452.9K | |
Other Stockholder Equity | 103.4M | 135.2M | 139.1M | 145.5M | 150.5M | 158.1M | |
Total Liab | 5.3M | 4.2M | 5.3M | 4.9M | 4.6M | 4.8M | |
Total Current Assets | 6.4M | 22.7M | 13.5M | 7.9M | 1.5M | 1.4M | |
Common Stock | 7K | 16K | 17K | 20K | 24K | 22.8K | |
Current Deferred Revenue | 732K | 1.4M | 1.5M | 965K | 561K | 732.7K | |
Inventory | 4K | (850K) | 1.0 | (201K) | (180.9K) | (171.9K) | |
Net Tangible Assets | 2.4M | 19.2M | 10.4M | 4.9M | 5.6M | 5.5M | |
Retained Earnings Total Equity | (72.5M) | (86.4M) | (101.1M) | (116.1M) | (104.5M) | (99.2M) | |
Capital Surpluse | 83.5M | 90.1M | 103.4M | 135.2M | 155.5M | 163.3M | |
Property Plant Equipment | 1.2M | 712K | 2.1M | 1.8M | 2.0M | 2.1M | |
Net Invested Capital | 2.4M | 19.2M | 10.4M | 4.9M | (1.6M) | (1.5M) | |
Net Working Capital | 2.4M | 18.4M | 9.8M | 4.3M | (2.1M) | (2.0M) | |
Capital Stock | 7K | 16K | 17K | 20K | 24K | 16.9K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BiocardiaInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BiocardiaInc's short interest history, or implied volatility extrapolated from BiocardiaInc options trading.
Pair Trading with BiocardiaInc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BiocardiaInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BiocardiaInc will appreciate offsetting losses from the drop in the long position's value.Moving against BiocardiaInc Stock
0.56 | DYAI | Dyadic International Financial Report 8th of May 2024 | PairCorr |
0.43 | ELYM | Eliem Therapeutics Trending | PairCorr |
0.43 | JAGX | Jaguar Animal Health Financial Report 20th of May 2024 | PairCorr |
The ability to find closely correlated positions to BiocardiaInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BiocardiaInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BiocardiaInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BiocardiaInc to buy it.
The correlation of BiocardiaInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BiocardiaInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BiocardiaInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BiocardiaInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BiocardiaInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade BiocardiaInc Stock refer to our How to Trade BiocardiaInc Stock guide.Note that the BiocardiaInc information on this page should be used as a complementary analysis to other BiocardiaInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for BiocardiaInc Stock analysis
When running BiocardiaInc's price analysis, check to measure BiocardiaInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BiocardiaInc is operating at the current time. Most of BiocardiaInc's value examination focuses on studying past and present price action to predict the probability of BiocardiaInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BiocardiaInc's price. Additionally, you may evaluate how the addition of BiocardiaInc to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |
Is BiocardiaInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BiocardiaInc. If investors know BiocardiaInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BiocardiaInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.55) | Revenue Per Share 0.023 | Quarterly Revenue Growth (0.88) | Return On Assets (1.14) | Return On Equity (7.04) |
The market value of BiocardiaInc is measured differently than its book value, which is the value of BiocardiaInc that is recorded on the company's balance sheet. Investors also form their own opinion of BiocardiaInc's value that differs from its market value or its book value, called intrinsic value, which is BiocardiaInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BiocardiaInc's market value can be influenced by many factors that don't directly affect BiocardiaInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BiocardiaInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if BiocardiaInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BiocardiaInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.